Chemoreduction in the management of retinoblastoma
- PMID: 16139001
- DOI: 10.1016/j.ajo.2005.04.047
Chemoreduction in the management of retinoblastoma
Comment on
-
Effect on ocular survival of adding early intensive focal treatments to a two-drug chemotherapy regimen in patients with retinoblastoma.Am J Ophthalmol. 2005 Sep;140(3):397-406. doi: 10.1016/j.ajo.2005.03.037. Am J Ophthalmol. 2005. PMID: 16138999
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
